Mohali, Punjab, India, June 29, 2015 --(PR.com
)-- Roots Analysis has announced the addition of the “Prefilled Syringes Market, 2015-2015 (3rd Edition)” report to their offerings. The study focuses on analysing the existing market size and potential future growth of these drug delivery devices across different therapeutic classes and regions. These modern injectables have become preferred devices for parenteral administration of drugs, mainly used for the treatment of chronic conditions requiring patients to self-administer medication several times a week.
Simriti Gupta, the principal analyst, stated, “As prefilled syringes provide advantages over conventional systems, these are being widely adopted by healthcare workers and patients even in emerging economies such as India and China. To exploit this potential, companies are constantly innovating technology for improving the compatibility of syringes with biologics to provide better extractables and leachables profiles. In addition, improved ergonomic designs now offer comfortable administration of drugs.
"A key objective of the report is to enumerate various prefilled syringe systems available in the market, drugs available in these syringes and the corresponding market potential across different geographical regions. We have discussed various historical/likely future trends which have shaped/will shape the US, European, Japanese, Chinese, Indian and other markets. We have also included a detailed overview of biologics and biosimilars, one of the primary growth drivers of this market.”
Gupta added “Over 65 drugs and vaccines are already available in prefilled syringes across different therapeutic classes. The emergence of biologics will be a major growth driver as several more in clinical pipeline are being tested in prefilled syringes.”
In an effort to identify existing gaps and future opportunities, the report discusses the leading global prefilled syringe manufacturers in the industry, analyses their product portfolios and the likely future developments driven by these companies. In addition, the report contains profiles of some important prefilled syringe component manufacturers as well as manufacturers of self-injection systems that use prefilled syringes as their primary drug containers.
The five leading companies, covered in detail, include:
- Becton Dickinson (BD)
- Nuova Ompi
In addition to these five companies, there are several other companies developing prefilled syringes including West Pharmaceuticals, Unilife, Vetter Pharma and Aguettant.
For additional details, please visit
or email firstname.lastname@example.org